Atlas Trials

Study of Danicopan in Participants With Hepatic Impairment

Clinical trial NCT03555539 · COMPLETED

Trial details

NCT number
NCT03555539
Sponsor
Alexion Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2018-05-01
Primary completion
2018-09-21
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.